Eris Lifesciences Limited

₹1,253As of Sun 8 Nov 2026, 12:00 UTC
NSE:ERISHealthcare
Country India
PE (Fwd) •••
TSR 9Y CAGR 8.70%
Div yield 0.58%
ROE 18.79%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.05)
PE TTM 24.43
TSR TTM (20.88%)
Mkt cap ₹173.8B
ROIC 14.00%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,228
(1.95%)
40.50%
Hold 2|3|1|12|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
22.30
24.09
25.82
27.18
12.28%
19.39%
27.06%
33.33%
Revenue₹B
9.459
9.819
10.35
10.85
5.29%
11.69%
11.25%
13.53%
Peers (US$1.827B)
Cap (US$)
PE
1.816B
19.49x
Capital
TTM
5Y
10Y
Leveragex
0.409
0.070
0.061
EBIT/Intx
1.658
0.280
0.283
Own earn%
764.04
312.34
284.49
Sh yield%
26.39
21.18
19.27
Owners
Insiders/Inst%
10.97
27.96
Short interest%
4.76
SBC / revenue%
2.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–9
$1 testx
3.4
Incr. ROIC%
2